JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Tel: +1-832-696-8203
Email: [email protected]
Worldwide Distributors
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
Animal models
Rats or monkeys
Dosage form
0.25 ~ 10 mmol/kg; i.v
Applications
In rats, a single dose of Gadodiamide at a greater than 0.5 mmol/kg induced vacuolization of the proximal tubular cells in kidneys, without affecting renal function. At a dose up to 10 mmol/kg, the vacuolization was only at the moderate degree, and was shown to regress partially during the 7 days after administration. In monkeys, administration of 0.25 mmol/kg Gadodiamide (q.d.; for 28 days) exhibited no effect on the kidneys.
Other notes
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.
References:
[1]. Harpur ES, Worah D, Hals PA, Holtz E, Furuhama K, Nomura H. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol. 1993 Mar;28 Suppl 1:S28-43.